Results 211 to 220 of about 130,240 (311)

Hepatitis B Vaccine Is Not Associated with Liver Problems in U.S. Children Less Than 6 Years Old

, 2000
Anthony E. Fiore, Greg Armstrong, Eric E. Mast, Beth P. Bell, Harold S. Margolis   +4 more
openalex   +2 more sources

How do I interpret transfusion transmissible infectious disease testing in a low‐risk donor population?

Transfusion, EarlyView.
Abstract Background Blood donors represent a unique population. Pre‐donation screening questions, donor self‐deferral, and temporary deferral and re‐testing of repeat reactive donors result in lower prevalence of infectious disease compared to the general population.
Carmen L. Charlton, Mark Bigham, Sheila F. O'Brien, Steven J. Drews   +3 more
wiley   +1 more source

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR IMPROVES IMMUNOGENECITY OF HEPATITIS B VACCINE IN HEMODIALYSIS PATIENTS [PDF]

, 2000
PP VARMA, AK SETH, Rohan Malik, Chinmaya Mahapatra, PVS Rana   +4 more
openalex   +1 more source

The generation of tumor vaccines by adenovirus-enhanced transfection of cytokine genes into tumor cells [PDF]

, 1994
Berger, M., Birnstiel, Max L., Buschle, M., Cotten, Matt, Maass, Gerd, Schmidt, Walter, Skouteris, George G., Wagner, Ernst, Zatloukal, Kurt   +8 more
core   +1 more source

RECOMBINANT HEPATITIS B VACCINE IN INFANTS

, 1997
Johanna Goldfarb
openalex   +1 more source

Mapping disasters; the application of a disaster-sociological 'Theoretical superstructure' and methodology in a Prima Facie case for investigating the role of hepatitis B vaccines in the contamination of the Canadian blood supply with human immunodef [PDF]

, 2000
Olaf Krassnitzky
openalex   +1 more source

Update and new advances in fertility preservation and cancer

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Adolescents and young adults with a cancer diagnosis face unique challenges during treatment and into survivorship related to fertility and family building. This review provides an updated overview of the impact of cancer and its associated treatments, including novel treatments in male and female fertility.
Gwendolyn P. Quinn, Michelle Bayefsky, Brooke Cherven, Lauren V. Ghazal, Kara N. Goldman, Nina Francis Levin, Leena Nahata, Bobby Najari, Sameer Thakker, Daniel R. Greenberg, Joshua A. Halpern, Susan T. Vadaparampil   +11 more
wiley   +1 more source

Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease [PDF]

, 2001
Mehmet Arslan, Russell H. Wiesner, Corey Sievers, Kathleen S. Egan, Nizar N. Zein   +4 more
openalex   +1 more source

Birth prevalence, clinical sequelae, and management of congenital cytomegalovirus infections in Australia, 1999–2023: a national prospective study

Medical Journal of Australia, EarlyView.
Abstract Objectives To investigate the birth prevalence, clinical manifestations, and management of congenital cytomegalovirus (CMV) infections in Australia, 1999–2023. Study design Longitudinal observational study; analysis of prospectively collected Australian Paediatric Surveillance Unit (APSU) data. Setting, participants Australia, 1 January 1999 –
Ece Egilmezer, Suzy M Teutsch, Carlos Nunez, Stuart T Hamilton, Adam W Bartlett, Pamela Palasanthiran, Elizabeth J Elliott, William D Rawlinson   +7 more
wiley   +1 more source

Hepatitis B Boosters Using a Different Product vs. the Same Product for Kidney Transplant Recipients: A Retrospective Study With Bayesian Inference. [PDF]

Clin Transplant
Iwata K, Ikegaki S, Hyodo Y, Miyake H.
europepmc   +1 more source